IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis

Journal: Nature Communications

Published: 2019-12-16

DOI: 10.1038/s41467-019-13731-z

Affiliations: 22

Authors: 28

Go to article
Institutions Share
Institute for Medical Microbiology and Hygiene, Uni Marburg, Germany 0.23
Department of Neurology, JGU, Germany 0.11
Department of Infection and Immunity (DII), LIH, Luxembourg 0.08
Institute of Immunology, JGU, Germany 0.07
Institute for Molecular Medicine Mainz, JGU, Germany 0.05
University of Giessen and Marburg Lung Center (UGMLC), Germany 0.05
Lautenberg Center for Immunology and Cancer Research, HUJI, Israel 0.04
Institute of Pharmacology and Toxicology, VUM, Austria 0.04
German Center for Infection Research (DZIF), Germany 0.04
TUM Center for Translational Cancer Research (TranslaTUM), Germany 0.04
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia 0.04
The Peter Doherty Institute for Infection and Immunity (Doherty Institute), Australia 0.04
Faculty of Medicine, Uni Marburg, Germany 0.04
Department of Dermatology at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.02
Center of Thrombosis and Haemostasis (CTH), JGU, Germany 0.02
Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), JGU, Germany 0.02
University Hospital Gießen and Marburg GmbH (UKGM), Germany 0.02
Department of Gastroenterology and Hepatology, Erasmus MC, Netherlands 0.02
Flow Cytometry Core Facility Marburg, Uni Marburg, Germany 0.02
Research Center for Immunotherapy (FZI), JGU, Germany 0.02
Luxembourg Centre for Systems Biomedicine (LCSB), Luxembourg 0.01
Odense Research Center for Anaphylaxis (ORCA), OUH SDU, Denmark 0.01